AWS GraphRAG cuts drug development time by 87%: one unified graph instead of separate databases

At a recent conference, AWS presented a case study: deploying GraphRAG at a pharmaceutical company cut drug R&D cycles by 87%.

The problem

The pharmaceutical company worked with 10+ internal proprietary databases: molecular structures, test results, literature, clinical data and metabolic models. A researcher starting a new project had to:

• Query each system separately
• Integrate the results by hand
• Look for relationships between different sources
• All of this took 6+ months

The solution

GraphRAG merged all the databases into one knowledge graph: nodes (molecules, tests, people) and edges (the links between them). Now a question such as "which molecules are similar to Aspirin and showed good results in the liver?" is run against the whole graph at once.

Results

• 87% faster: weeks instead of 6+ months for screening
• The success rate of the early phases rose from 5% previously
• Researchers can query the graph without learning the SQL of each database

What this means

GraphRAG shows that unifying data through a knowledge graph is not just a convenience but an accelerator of discovery. Companies with fragmented systems (which is most of them) lose months on integration. The graph solves the problem at the architectural level.